Proceedings of the National Academy of Sciences · 2020 · 89 citations · 55 references
Life SciencesCell BiologyMolecular BiologyEpigeneticsGene ExpressionSignal TransductionChromatinEpigenetic Control Of DifferentiationExtracellular MatrixFibrosisFibrous ProteinsInflammatory SignalingAnimal Disease ModelsEpigenetic RegulationEpigenetic Regulation Of FibrosisFibrosis ModulationFibrotic ChangeFibrotic Tissue RemodelingMyofibroblast DifferentiationTherapeutic Target Identification
Genomic analysis revealed that EP300 is highly enriched at enhancers associated with genes involved in multiple profibrotic pathways, and broad transcriptomic and proteomic profiling of CREBBP/EP300 inhibition by the chemical probe SGC-CBP30 identified collagen VI (Col VI) as a prominent downstream regulator of myofibroblast activity. Targeted Col VI knockdown results in significant decrease in profibrotic functions, including myofibroblast contractile force, extracellular matrix (ECM) production, chemotaxis, and wound healing. Further evidence for Col VI as a major determinant of fibrosis is its abundant expression within Dupuytren's nodules and also in the fibrotic foci of idiopathic pulmonary fibrosis (IPF). Thus, Col VI may represent a tractable therapeutic target across a range of fibrotic disorders.
55
Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
Warren A. Whyte, David A. Orlando, Denes Hnisz et al. · Cell · 2013 · 4.3K citations · Full text
Systematic Localization of Common Disease-Associated Variation in Regulatory DNA
Matthew T. Maurano, Richard Humbert, Eric Rynes et al. · Science · 2012 · 4K citations · Full text
Super-Enhancers in the Control of Cell Identity and Disease
Denes Hnisz, Brian J. Abraham, Tong Ihn Lee et al. · Cell · 2013 · 3.9K citations · Full text
Histone modifications at human enhancers reflect global cell-type-specific gene expression
Nathaniel D. Heintzman, Gary C. Hon, R. David Hawkins et al. · Nature · 2009 · 2.6K citations · Full text